| (NOK) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NYKD.OL returned +161.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +89.1% |
| 1 year | +161.0% |
| 5 years | -91.0% |
| All-time high | kr 87.30 (May 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in NYKD.OL would be worth today ›No. Nykode Therapeutics AS has not paid a dividend in the past 12 months.
Nykode Therapeutics AS is part of the Healthcare sector.
Nykode Therapeutics AS has a market cap of 1.49B NOK, based on the latest quote.
Nykode Therapeutics AS is scheduled to report earnings on Aug 26, 2026.
